• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏胰岛素抵抗与微小RNA调节因子

Cardiac insulin resistance and microRNA modulators.

作者信息

Pulakat Lakshmi, Aroor Annayya R, Gul Rukhsana, Sowers James R

机构信息

Department of Internal Medicine, School of Medicine, University of Missouri, Columbia, MO 65212, USA.

出版信息

Exp Diabetes Res. 2012;2012:654904. doi: 10.1155/2012/654904. Epub 2011 Jul 31.

DOI:10.1155/2012/654904
PMID:21977024
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3184440/
Abstract

Cardiac insulin resistance is a metabolic and functional disorder that is often associated with obesity and/or the cardiorenal metabolic syndrome (CRS), and this disorder may be accentuated by chronic alcohol consumption. In conditions of over-nutrition, increased insulin (INS) and angiotensin II (Ang II) activate mammalian target for rapamycin (mTOR)/p70 S6 kinase (S6K1) signaling, whereas chronic alcohol consumption inhibits mTOR/S6K1 activation in cardiac tissue. Although excessive activation of mTOR/S6K1 induces cardiac INS resistance via serine phosphorylation of INS receptor substrates (IRS-1/2), it also renders cardioprotection via increased Ang II receptor 2 (AT2R) upregulation and adaptive hypertrophy. In the INS-resistant and hyperinsulinemic Zucker obese (ZO) rat, a rodent model for CRS, activation of mTOR/S6K1signaling in cardiac tissue is regulated by protective feed-back mechanisms involving mTOR↔AT2R signaling loop and profile changes of microRNA that target S6K1. Such regulation may play a role in attenuating progressive heart failure. Conversely, alcohol-mediated inhibition of mTOR/S6K1, down-regulation of INS receptor and growth-inhibitory mir-200 family, and upregulation of mir-212 that promotes fetal gene program may exacerbate CRS-related cardiomyopathy.

摘要

心脏胰岛素抵抗是一种代谢和功能紊乱,常与肥胖和/或心肾代谢综合征(CRS)相关,这种紊乱可能因长期饮酒而加剧。在营养过剩的情况下,胰岛素(INS)和血管紧张素II(Ang II)增加会激活哺乳动物雷帕霉素靶蛋白(mTOR)/p70核糖体蛋白S6激酶(S6K1)信号通路,而长期饮酒会抑制心脏组织中mTOR/S6K1的激活。虽然mTOR/S6K1的过度激活通过胰岛素受体底物(IRS-1/2)的丝氨酸磷酸化诱导心脏胰岛素抵抗,但它也通过增加血管紧张素II受体2(AT2R)的上调和适应性肥大提供心脏保护作用。在胰岛素抵抗和高胰岛素血症的Zucker肥胖(ZO)大鼠(一种CRS的啮齿动物模型)中,心脏组织中mTOR/S6K1信号通路的激活受涉及mTOR↔AT2R信号环和靶向S6K1的微小RNA谱变化的保护性反馈机制调节。这种调节可能在减轻进行性心力衰竭中起作用。相反,酒精介导的mTOR/S6K1抑制、胰岛素受体下调和生长抑制性mir-200家族以及促进胎儿基因程序的mir-212上调可能会加重CRS相关的心肌病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f021/3184440/3be98651beeb/EDR2012-654904.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f021/3184440/8f9f636ac67a/EDR2012-654904.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f021/3184440/9ebfac7b9651/EDR2012-654904.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f021/3184440/90d118df8a0c/EDR2012-654904.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f021/3184440/3be98651beeb/EDR2012-654904.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f021/3184440/8f9f636ac67a/EDR2012-654904.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f021/3184440/9ebfac7b9651/EDR2012-654904.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f021/3184440/90d118df8a0c/EDR2012-654904.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f021/3184440/3be98651beeb/EDR2012-654904.004.jpg

相似文献

1
Cardiac insulin resistance and microRNA modulators.心脏胰岛素抵抗与微小RNA调节因子
Exp Diabetes Res. 2012;2012:654904. doi: 10.1155/2012/654904. Epub 2011 Jul 31.
2
Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance.肥胖大鼠肝脏和骨骼肌中雷帕霉素靶蛋白通路的激活增加:可能与肥胖相关的胰岛素抵抗有关。
Endocrinology. 2005 Mar;146(3):1473-81. doi: 10.1210/en.2004-0921. Epub 2004 Dec 16.
3
Adaptive mechanisms to compensate for overnutrition-induced cardiovascular abnormalities.适应机制以补偿营养过剩引起的心血管异常。
Am J Physiol Regul Integr Comp Physiol. 2011 Oct;301(4):R885-95. doi: 10.1152/ajpregu.00316.2011. Epub 2011 Aug 3.
4
Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) and c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathways.抵抗素通过 AMP 激活的蛋白激酶/雷帕霉素靶蛋白(AMPK/mTOR)和 c-Jun N-末端激酶/胰岛素受体底物 1(JNK/IRS1)通路促进心肌肥大。
J Biol Chem. 2011 May 27;286(21):18465-73. doi: 10.1074/jbc.M110.200022. Epub 2011 Apr 8.
5
Alpha-synuclein overexpression negatively regulates insulin receptor substrate 1 by activating mTORC1/S6K1 signaling.α-突触核蛋白过表达通过激活mTORC1/S6K1信号通路负向调节胰岛素受体底物1。
Int J Biochem Cell Biol. 2015 Jul;64:25-33. doi: 10.1016/j.biocel.2015.03.006. Epub 2015 Mar 23.
6
miR-155-5p alleviates ethanol-induced myocardial insulin resistance in H9C2 cells via regulating the mTOR signalling pathway.miR-155-5p 通过调控 mTOR 信号通路减轻乙醇诱导的 H9C2 心肌细胞胰岛素抵抗。
Mol Biol Rep. 2020 Dec;47(12):9469-9477. doi: 10.1007/s11033-020-05967-6. Epub 2020 Nov 7.
7
AMPD1 regulates mTORC1-p70 S6 kinase axis in the control of insulin sensitivity in skeletal muscle.AMPD1通过调控mTORC1-p70 S6激酶轴来控制骨骼肌中的胰岛素敏感性。
BMC Endocr Disord. 2015 Mar 27;15:11. doi: 10.1186/s12902-015-0010-9.
8
hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase.人Vps34是一种营养调节脂质激酶,是p70 S6激酶激活所必需的。
J Biol Chem. 2005 Sep 23;280(38):33076-82. doi: 10.1074/jbc.M507201200. Epub 2005 Jul 27.
9
Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.雷帕霉素哺乳动物靶点通路的激活会急性抑制3T3-L1细胞和人脂肪细胞中胰岛素向Akt的信号传导以及葡萄糖转运。
Endocrinology. 2005 Mar;146(3):1328-37. doi: 10.1210/en.2004-0777. Epub 2004 Dec 2.
10
Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1).PF-4708671 的特性研究,一种新型、高特异性的 p70 核糖体 S6 激酶(S6K1)抑制剂。
Biochem J. 2010 Oct 15;431(2):245-55. doi: 10.1042/BJ20101024.

引用本文的文献

1
A Bibliometric and Visualization Analysis of Metabolic Reprogramming in Cardiovascular Diseases: Trends, Key Contributors, and Future Directions from 2000 to 2024.心血管疾病中代谢重编程的文献计量与可视化分析:2000年至2024年的趋势、主要贡献者及未来方向
Curr Cardiol Rev. 2025;21(4):e1573403X371021. doi: 10.2174/011573403X371021250109064231.
2
Cardiorenal syndrome: clinical diagnosis, molecular mechanisms and therapeutic strategies.心肾综合征:临床诊断、分子机制及治疗策略
Acta Pharmacol Sin. 2025 Feb 5. doi: 10.1038/s41401-025-01476-z.
3
mTOR Dysregulation, Insulin Resistance, and Hypertension.

本文引用的文献

1
The Role of Overweight and Obesity in the Cardiorenal Syndrome.超重和肥胖在心肺肾综合征中的作用。
Cardiorenal Med. 2011;1(1):5-12. doi: 10.1159/000322822. Epub 2011 Jan 17.
2
The Impact of Overnutrition on Insulin Metabolic Signaling in the Heart and the Kidney.营养过剩对心脏和肾脏胰岛素代谢信号的影响。
Cardiorenal Med. 2011;1(2):102-112. doi: 10.1159/000327140. Epub 2011 Apr 15.
3
Adaptive mechanisms to compensate for overnutrition-induced cardiovascular abnormalities.适应机制以补偿营养过剩引起的心血管异常。
哺乳动物雷帕霉素靶蛋白失调、胰岛素抵抗与高血压
Biomedicines. 2024 Aug 8;12(8):1802. doi: 10.3390/biomedicines12081802.
4
Comparison of Cardiac miRNA Transcriptomes Induced by Diabetes and Rapamycin Treatment and Identification of a Rapamycin-Associated Cardiac MicroRNA Signature.糖尿病和雷帕霉素治疗诱导的心脏 miRNA 转录组比较及雷帕霉素相关心脏 miRNA 特征的鉴定。
Oxid Med Cell Longev. 2018 Dec 17;2018:8364608. doi: 10.1155/2018/8364608. eCollection 2018.
5
The two faces of miR-29.miR-29的两面性
J Cardiovasc Med (Hagerstown). 2015 Jul;16(7):480-90. doi: 10.2459/JCM.0000000000000246.
6
Noncoding RNA in age-related cardiovascular diseases.与年龄相关的心血管疾病中的非编码RNA
J Mol Cell Cardiol. 2015 Jun;83:142-55. doi: 10.1016/j.yjmcc.2015.01.011. Epub 2015 Jan 29.
7
Overnutrition, mTOR signaling, and cardiovascular diseases.营养过剩、mTOR 信号通路与心血管疾病
Am J Physiol Regul Integr Comp Physiol. 2014 Nov 15;307(10):R1198-206. doi: 10.1152/ajpregu.00262.2014. Epub 2014 Sep 24.
8
Oxidative stress and microRNAs in vascular diseases.氧化应激与血管疾病中的 microRNAs
Int J Mol Sci. 2013 Aug 22;14(9):17319-46. doi: 10.3390/ijms140917319.
9
Dipeptidylpeptidase inhibition is associated with improvement in blood pressure and diastolic function in insulin-resistant male Zucker obese rats.二肽基肽酶抑制与胰岛素抵抗雄性 Zucker 肥胖大鼠血压和舒张功能改善相关。
Endocrinology. 2013 Jul;154(7):2501-13. doi: 10.1210/en.2013-1096. Epub 2013 May 7.
10
Potential biofluid markers and treatment targets for renal cell carcinoma.肾细胞癌的潜在生物体液标志物和治疗靶点。
Nat Rev Urol. 2013 Jun;10(6):336-44. doi: 10.1038/nrurol.2013.52. Epub 2013 Apr 2.
Am J Physiol Regul Integr Comp Physiol. 2011 Oct;301(4):R885-95. doi: 10.1152/ajpregu.00316.2011. Epub 2011 Aug 3.
4
MicroRNAs in development and disease.微小 RNA 在发育和疾病中的作用。
Physiol Rev. 2011 Jul;91(3):827-87. doi: 10.1152/physrev.00006.2010.
5
ALDH2 in alcoholic heart diseases: molecular mechanism and clinical implications.醇性心脏病中 ALDH2 的作用:分子机制与临床意义。
Pharmacol Ther. 2011 Oct;132(1):86-95. doi: 10.1016/j.pharmthera.2011.05.008. Epub 2011 Jun 12.
6
mTOR-STAT3-notch signalling contributes to ALDH2-induced protection against cardiac contractile dysfunction and autophagy under alcoholism.mTOR-STAT3-notch 信号通路有助于 ALDH2 诱导的酒精中毒性心肌收缩功能障碍和自噬保护。
J Cell Mol Med. 2012 Mar;16(3):616-26. doi: 10.1111/j.1582-4934.2011.01347.x.
7
mTOR signaling in protein homeostasis: less is more?mTOR 信号在蛋白质动态平衡中的作用:少即是多?
Cell Cycle. 2011 Jun 15;10(12):1940-7. doi: 10.4161/cc.10.12.15858.
8
Resistin: functional roles and therapeutic considerations for cardiovascular disease.抵抗素:在心血管疾病中的功能作用和治疗考虑。
Br J Pharmacol. 2012 Feb;165(3):622-32. doi: 10.1111/j.1476-5381.2011.01369.x.
9
MicroRNA therapeutics.微小 RNA 治疗学。
Gene Ther. 2011 Dec;18(12):1104-10. doi: 10.1038/gt.2011.50. Epub 2011 Apr 28.
10
MicroRNA response to environmental mutagens in liver.环境诱变剂在肝脏中对 microRNA 的影响。
Mutat Res. 2011 Dec 1;717(1-2):67-76. doi: 10.1016/j.mrfmmm.2011.03.015. Epub 2011 Apr 14.